Abbvie Inc (ABBV) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abbvie Inc   (NYSE: ABBV)


Abbvie Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abbvie Inc's ROI in the third quarter of 2026?
Abbvie Inc achieved a return on average invested assets (ROI) of 13.27 % in its third quarter of 2026, this is above ABBV's average return on investment of 11.1%.
Abbvie Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $77 billion

ROI has improved compared to 9.44% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 41 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1313, from total ROI ranking in the second quarter of 2026 at 1388.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 23.24 % 4.04 % -8.6 % -7.58 % -4.16 %
Y / Y Net Income Change TTM 331.98 % 67.49 % 28.66 % 174.69 % 53.13 %
Investment (TTM) in Millions 104,623 93,520 57,964 55,755 60,415
Return On Investment (TTM) 13.27 % 9.44 % 6.15 % 6.91 % 3.79 %
ABBV's Overall Ranking # 1313 # 1388 # 1586 # 1200 # 1149
Seq. Investment Change TTM 16.52 % 12.93 % -3.29 % -3.16 % -1.63 %
Seq. Net Income Change TTM 63.81 % 73.47 % -13.99 % 76.74 % -36.49 %
Net Income (TTM) in Millions 10,346 6,316 3,641 4,233 2,395

ABBV Company Profile >> Back to ABBV Roi Comparisons >> See Annual ABBV Return On Investment



Return On Investment ABBV's Ranking
Within: No.
Industry # 18
Sector # 42
Overall # 1313

Return On Investment Statistics
High Average Low
22.87 %
11.1 %
3.64 %
(Sep. 30, 2013)  







Financial Statements
Abbvie Inc's III. Quarter Investments $ 104,623 Millions ABBV's Balance sheet
Abbvie Inc's III. Quarter Income $ 4,218 Millions Quarterly ABBV's Income Statement
ABBV's Income by Division See ABBV's Income by Division


ABBV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 55,755 63,743 62,628 76,455 108,354
Y / Y Investment Growth -12.53 % 1.78 % -18.09 % -29.44 % -8.39 %
Net Income in Millions 4,233 4,286 4,873 11,845 11,549
Y / Y Net Income Growth -1.24 % -12.05 % -58.86 % 2.56 % 149.87 %
Annual Return On Investment 7.59 % 6.72 % 7.78 % 15.49 % 10.66 %


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 7.59 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABBV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABBV's Competitors
Subscribers only: Roi for Abbvie Inc's Suppliers
Subscribers only: Return On Investment for ABBV's Customers

Other Ratios
ABBV's Roa ABBV's Inventory Turnover Ratio ABBV's Growth Rates ABBV's Dividend Statistics
ABBV's Profitability Ratios ABBV's Asset Turnover Ratio ABBV's Dividend Growth
ABBV's Roe ABBV's Valuation Ratios ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %

Date modified: 2026-11-04T15:04:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.